Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFeedback Regulatory News (FDBK)

Share Price Information for Feedback (FDBK)

Share Price is delayed by 15 minutes
Get Live Data
7.40    0.00 (0.00%)
Bid:
7.30
Ask:
7.50
Spread: 0.20 (2.74%)
Market Cap: £3.24m
FDBK Live PriceLast checked at - London Stock Exchange

Intraday Feedback Share Chart

Issue of Equity

28 Sep 2011 07:00

RNS Number : 0540P
Feedback PLC
28 September 2011
Β 

ο»Ώ

28 September 2011

Feedback plc

("Feedback" or "the Company")

Β 

Proposed subscription to raise Β£272,500

Β 

Feedback is pleased to announce that it has raised Β£272,500 (the "Subscription") through the issue of 21,800,000 new ordinary shares in the capital of the Company at a subscription price of 1.25 pence per share (the "Subscription Shares") to certain Directors of the Company, Institutional and other investors.

Β 

Certain directors of the Company have agreed to subscribe for an aggregate of 10,158,755 Subscription Shares as part of the Subscription. The respective subscriptions, together with the resultant holdings in the enlarged issued share capital are as follows:

Β 

No. of Subscription Shares

Shareholding following Admission

Percentage holding of enlarged issued share capital

David Barton, Non-executive Director*

2,621,204

15,744,871

12.02

John Westcott, Non-executive Director**

1,537,551

5,999,287

4.58

Nick Shepheard, Executive Chairman

5,000,000

5,000,000

3.82

Mark Bird, Group Sales Director

1,000,000

1,000,000

0.76

Β 

*David Barton's holding includes 2,250,000 ordinary shares held by Huntley Securities Pension Fund of which Mr Barton is the sole beneficiary.

** - includes 3,548,748 ordinary shares held by his wife.

Β 

In addition, Tom Charlton, a substantial shareholder of the Company, has agreed to subscribe for 2,600,000 Subscription Shares. Following Admission, Mr Charlton will be beneficially interested in a total of 19,238,397 ordinary shares, equivalent to 14.69 per cent. of the enlarged issued share capital of the Company.

Β 

The Directors' aggregated participation in the Subscription constitutes a related party transaction in accordance with the AIM Rules. In accordance with Rule 13 of the AIM Rules, David John Marks ("the Independent Director"), having consulted with Merchant Securities Limited, the Company's Nominated Adviser, considers the terms of the Subscription to be fair and reasonable insofar as the shareholders of the Company are concerned. In advising the Independent Director, Merchant Securities Limited has relied upon the commercial assessment of the Independent Director.

Β 

Application will be made for the Subscription Shares to be admitted to trading on AIM. Admission is expected to become effective and dealings are expected to commence on AIM on 3 October 2011. Following the issue of the Subscription Shares, the Company will have 130,946,746 ordinary shares in issue.

Β 

For further information contact:

Β 

Feedback plc

Tel: 01892 653 322

Nick Shepheard

Merchant Securities Limited

Simon Clements/Lindsay Mair

Tel: 020 7628 2200

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IOEZMGZLNNFGMZM
Date   Source Headline
22nd Apr 20262:10 pmRNSGrant of Options and PDMR dealing
20th Apr 20267:00 amRNSNHS Progress and Business Update
17th Feb 202610:43 amRNSCorrection: Half-year Report
17th Feb 20267:00 amRNSHalf-year Report
2nd Feb 20267:00 amRNSNotice of Results & Retail Investor Presentation
5th Jan 20264:13 pmRNSHolding(s) in Company
23rd Dec 20253:44 pmRNSHolding(s) in Company
23rd Dec 20253:44 pmRNSHolding(s) in Company
23rd Dec 20253:33 pmRNSDirector/PDMR Shareholding
23rd Dec 20253:33 pmRNSDirector/PDMR Shareholding
18th Dec 20257:00 amRNSTrading Update
20th Oct 20257:00 amRNSDirectorate Change
13th Oct 20254:04 pmRNSResult of AGM
18th Sep 20251:07 pmRNSNotice of AGM
17th Sep 20257:00 amRNSFinal Results
8th Sep 20257:00 amRNSNotice of Results & Retail Investor Presentation
10th Jul 20257:00 amRNSGrant of Options and PDMR dealing
12th Jun 20257:00 amRNS-RNeighbourhood Health Service Simulation
7th May 202510:44 amRNSHolding(s) in Company
6th May 20251:01 pmRNSHolding(s) in Company
28th Apr 20257:00 amRNSTrading Update
25th Feb 20257:00 amRNSHalf-year Report
11th Feb 20257:00 amRNSNotice of Results & Investor Presentation
14th Jan 20257:00 amRNSSurrender and grant of options and PDMR dealings
18th Dec 20243:07 pmRNSHolding(s) in Company
18th Dec 20247:00 amRNSHalf Year Trading Update
9th Dec 202410:56 amRNSHolding(s) in Company
9th Dec 202410:48 amRNSHolding(s) in Company
4th Dec 20247:00 amRNSHolding(s) in Company
3rd Dec 202412:33 pmRNSHolding(s) in Company
3rd Dec 202412:18 pmRNSHolding(s) in Company
2nd Dec 202411:53 amRNSHolding(s) in Company
2nd Dec 202411:46 amRNSHolding(s) in Company
2nd Dec 20247:00 amRNSDirector/PDMR Shareholding
29th Nov 20243:36 pmRNSHolding(s) in Company
29th Nov 20243:33 pmRNSHolding(s) in Company
28th Nov 20242:35 pmRNSResult of AGM & Commercial Update
6th Nov 20247:00 amRNSResult of WRAP Retail Offer
4th Nov 20243:46 pmRNSSuccessful Fundraising upscaled to c. £5.57m
4th Nov 20247:02 amRNSWRAP Retail Offer for up to £1 million
4th Nov 20247:01 amRNSProposed Fundraise & Share Capital Reorganisation
4th Nov 20247:00 amRNSFinal Results
16th Oct 20247:00 amRNSElective Recovery Fund funding mechanism
19th Sep 20247:00 amRNSCollaboration Agreement
2nd Sep 20247:00 amRNSFurther funding to extend NHS Trust pathways
10th Jul 20247:00 amRNSVertex In Healthcare Collaboration
1st Jul 20247:00 amRNSCDC Contract Awarded by Queen Victoria Hospital
28th Jun 20247:00 amRNSChange of Name of Nominated Adviser and Broker
22nd May 20247:00 amRNSTrading Update
25th Mar 20247:00 amRNSNew tuberculosis partnership in India

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.